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is an oxidoreduction involving a thiol and a protein 
disulphide, or more simply a thiohprotein-disulphide 
interchange. Reactions of this kind are components 
of several rather diverse cellular processes most of 
which are poorly characterised. In particular, few 
enzymes catalysing thiol:protein-disulphide int r- 
change have been described in detail and their 
physiological functions are still subjects for debate. 
This review aims: 
(i) To set out the different cellular processes involving 
thiohprotein-disulphide int rchange and to argue 
that these suggest the existence of several enzyme 
species; 
(ii) To review what is known about enzymes 
catalysing such reactions; 
(iii) To consider the problems in assigning physiological 
roles to such enzymes; 
(iv) To suggest how ambiguities about physiological 
function may be minimized and how the various 
enzymes catalysing thiol:protein-disulphide int r- 
change in a specific source may be enumerated. 
2. Diversity of processes involving thiohprotein- 
disulphide interchange 
Depending on the nature of the thiol compound, 
thiol :protein-disulphide interchanges can have rather 
different overall consequences. With a low molecular 
weight hiol, the product is a mixed disulphide and 
protein thiol (reaction 1a) and further eaction with a 
low molecular weight hiol will lead to complete 
reduction of the protein disulphide (reaction lb). If 
the thiol is a component of a distinct polypeptide 
chain, the interchange r action leads to the formation 
of an interchain disulphide bond (reaction 2), whereas 
if the thiol is located in the same polypeptide chain 
as the disulphide, the consequence is an intramolecular 
rearrangement of disulphide and thiol groups (reac- 
tion 3). A combination of reactions (la) and (3) can 
lead to the complete isomerization of disulphide 
bonds in a fully oxidised protein (reaction 4). 
Examples of all these processes have been observed 
in vitro, and they have been proposed to be involved 
in numerous cellular events. 
2.1. Reduction of  protein disulphides and mixed 
disulphides 
Studies on the metabolism of polypeptide hor- 
mones, especially insulin, have indicated that 
reduction of their disulphide bonds plays an important 
part in their degradation [1-7]. Studies on insulin 
degradation using whole cells [7], homogenates 
[1-3,5,6] and sub-cellular f actions [4,8] show that 
the reduced A chain and various ill-characterised 
oligomers of the A and B chains are major 
products. Considerable evidence has been advanced 
showing that a two-step athway of degradation - 
reduction followed by proteolysis - occurs at both 
high and at physiological insulin concentrations 
[5-7]. Although this is not universally accepted as 
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the obligatory pathway of insulin degradation (see, 
e.g., [9] ) it is certainly the case that many tissues 
have the capacity to reduce insulin. It has always 
been assumed that glutathione, the predominant low 
molecular weight intracellular thiol compound, is the 
reductant in this process. A ghitathione:insulin 
oxidoreductase, commonly known as glutathione- 
insulin transhydrogenase (GIT) has been identified in 
several sources and studied in some detail (see below). 
Disulphide reduction is also important in the 
metabolism of other polypeptide hormones. 
Glutathione:oxytocin oxidoreductase activity has 
been detected in mouse mammary tissue [10] and 
human placental tissue [ 11 ], and the human 
placental activity has been shown to have a con- 
siderable specificity for oxytocin and vasopressin and 
quite a low activity with insulin. Neither of these 
systems has been characterised in any detail. 
The assumption that glutathione or a related low 
molecular weight hiol is the major reductant of 
protein disulphide bonds may not be wholly justified. 
The thioredoxin system, characterised byHolmgren 
and others (reviewed [12] ) may also play a part. 
Thioredoxin, a protein of tool. wt 12 000 was first 
discovered as a component of the system in 
Escherichia cog responsible for the reduction of 
ribonucleotides to deoxyribonucleotides [13]. The 
reduced form of thioredoxin - thioredoxin-(SH)~ - 
is the immediate reductant in this process; the dithiol 
is a strong reductant (redox potential --0.26 V at pH 7, 
25°C) and is converted to a product with an 
intramolecular 
S 
-C~'s-Gly-Pro-C~s - disulphide bond [14]. 
Thioredoxin is widely distributed in bacterial, lower 
eukaryote and mammalian sources [15]. 
The reduction of thioredoxin-S2 is brought about 
by an NADPH-dependent process involving the 
fiavoenzyme, thioredoxin reductase [16]. The com- 
bination of NADPH, thioredoxin reductase and 
thioredoxin-S2 ifi vitro, is capable of reducing 
disulphide bonds in low molecular weight compounds, 
such as cystine and in polypeptides such as insulin 
and human choriogonadotropin [16,17]. The system 
may be of considerable importance in reduction of 
disulphides in vivo but its role is not yet established. 
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It has recently been shown that the light-dependent 
regulation of the activity of key enzymes of CO2 
assimilation i  chloroplasts involves thioredoxin. 
Thioredoxin is reduced photochemicaUy via ferre- 
doxin and a ferredoxin-thioredoxin reductase, and 
the reduced thioredoxin reduces (and activates) 
fructose- 1,6-bisphosphatase, sedoheptulose- 1,7- 
bisphosphatase and possibly other enzymes [ 18]. In 
the dark, these nzymes are reoxidised (and inactivated), 
possibly by oxidised glutathione. In this scheme, both 
the activation and inactivation are thiol: protein- 
disulphide oxidoreductions [ 18]. This finding 
emphasizes the diversity of thioredoxin function. 
Mammalian liver thioredoxin s active in the reduction 
of disulphides in mammalian proteins, but also 
replaces bacterial thioredoxin i  the reduction of 
ribonucleotides to deoxyribonucleotides andreplaces 
chloroplast thioredoxin i the photoregulatory process 
outlined above [ 19]. 
Mixed disulphides between proteins and 
glutathione or cysteine are present in quite high intra- 
cellular concentrations. In several rat tissues, the con- 
centration of protein-SSG is 25-50% of the concen- 
tration of total acid-soluble thiol groups [20]. In rat 
liver, the concentration f protein-SSG at times 
exceeds that of GSH (see below). Thus a considerable 
proportion ofintracellular glutathione is in the form 
protein-SSG and this must play a part in the redox 
buffering effect of glutathione [21]. For example, 
exposure of rats to ozone leads to a fall in free 
ghitathione in the lung without any increase in GSSG; 
the fall in GSH is correlated with an increase in the 
level of protein-SSG [22]. 
The level of protein-SSG in rat liver shows a clear- 
cut diurnal variation, inversely correlated with a 
variation in the level of GSH [23]. The concentration 
of protein-SSG ismaximal (17 nmol/mg protein) at 
6 p.m. and minimal (5 nmol/mg) at 6 a.m. whereas 
that of GSH is minimal at 6 p.m. (13 nmol/mg) and 
maximal (25 nmol/mg) at 6 a.m. These changes may 
result from the diurnal variation in level of cAMP 
[24]. In rats fed ad libitum, the ratio of protein-SSG 
to GSH rises during the period when hepatic AMP 
levels are high and drops when hepatic AMP levels 
are low; furthermore, the ratio of protein-SSG to 
GSH in rat liver is increased by intraperitoneal 
injection of dibutyryl-cAMP. The fact that the 
activities of several enzymes of carbohydrate 
metabolism (notably fructose-1,6-bisphosphatase and 
phosphofructokinase) are altered by formation of 
mixed disulphides (see [24,25] ) suggests that this 
formation of mixed disulphides in response to diurnal 
variation in cAMP levels may have regulatory signifi- 
cance. 
So the formation ofprotein-SSG mixed disulphides 
may contribute to the redox buffering of the cell, the 
prevention of oxidant oxicity, and the modulation 
of the specific activity of certain proteins. In any 
case, the existence of such mixed disulphides implies 
the existence of a system for reducing them to 
generate the thiol group on the protein [26]. In crude 
systems these mixed disulphides are reducible by 
NADPH, but this is probably an indirect effect. There 
is good evidence that protein mixed disulphides are 
directly reduced by GSH in a thiohdisulphide 
oxidoreduction [27]; the requirement for NADPH 
in crude systems then arises from the necessity to 
regenerate GSH via glutathione reductase. The GSH: 
mixed disulphide oxidoreductase has been given the 
trivial name 'thioltransferase' [28] and characterised 
to some extent (see below). 
2.2. Formation of interpolypeptide isulphide bond 
Disulphide bonds between polypeptide chains are 
present in very many classes of extracellular p oteins 
including digestive nzymes, immunoglobulins, mucus 
glycoproteins and procollagens. Evidence is 
accumulating that certain proteins in plasma 
membranes may also exist in extensive disulphide 
crosslinked networks [29,30]. The mechanism of the 
formation of these bonds in vivo is obscure. 
The formation of interchain disulphide bonds has 
been most intensely studied in the case of the IgG 
immunoglobulins which consist of two heavy (H) 
chains and two light (L) chains linked by several 
disulphide bonds to give an L -H-H-L  structure. 
The course of assembly of this structure in vitro has 
been compared to that observed in vivo. However, 
much of the work on this assembly in vitro has used 
the non-physiological oxidant 02 [31,32] and even 
in cases where GSSG was employed as oxidant [33] 
the starting material was fully reduced but non- 
covalently associated H and L chains. So from these 
model studies it is difficult to draw conclusions as to 
the chemical events involved in in vivo assembly. 
However, the bulk of the evidence favours thioh 
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protein-disulphide interchange as the crucial reaction. 
Thus, in the GSSG-dependent coupling of H and L 
chains [33], the pathway appears to be: 
H -SH + GSSG ~ H -SSG + GSH; 
H -SSG + L -SH -+ H-SS- L + GSH 
Similarly, the formation of this 'half-molecule' can 
occur from reduced H chains and L chain dimers, a 
reaction which may occur in vivo since many cells 
synthesize L chains in excess over H chain and the 
excess L chain appears as the disulphide-linked L 
-SS- L dimer [34]. The reaction is probably a simple 
thiol:protein-disulphide nterchange of type (2): 
H -SH + L -SS- L ~ H -SS- L + L -SH 
In the case of polymeric immunoglobulins IgA and 
IgM, although the process of assembly is more com- 
plex, comparison of in vivo and in vitro data is easier 
because of the special role of the J chain. IgM consists 
of 5 H2L2 units linked by disulphide bonds between 
heavy chains. In the non-assembled form, IgMs, which 
accumulates intracellularly these residues are not 
found as free cysteine, but form an intramolecular 
disulphide bond [35] (see fig.l). Experiments on the 
assembly of IgM from reduced chains or from IgMs 
in vitro have shown an essential requirement for the 
J chain [36], and structural work on IgM has 
established that this chain forms a clasp in the cyclic 
pentameric structure [37]. The mechanism of 
assembly can therefore be postulated to be a thiol: 
disulphide interchange r action of type (2) (see 
scheme 1). Further evidence for this is the finding 
that the assembly of IgM in vitro is dependent on the 
presence ither of microsomal membranes or of 
protein-disulphide isomerase [36,38] an enzyme 
isolated from microsomal membranes which catalyses 
thiol:protein-disulphide nterchange (see below). 
Little is known about the process of interchain 
disulphide bond formation in other secreted proteins. 
In the case of procollagen, the evidence suggests that 
interchain disulphide bond formation occurs in the 
cisternae of the endoplasmic reticulum [39]. In this 
connection, it is interesting that protein-disulphide 
isomerase has been detected in microsomal prepara- 
tions from most sources, including collagen-synthesizing 
tissues [40]. However, in the case of mucins the 
evidence is that disulphide formation is a late intra- 
cellular event, just preceding secretion [41 ]. 
2.3. Intramolecular thiol: disulphide interchange 
Few proteins contain both disulphide bonds and 
free thiol groups [42]. In those cases where both 
coexist, there is the possibility of intramolecular 
thiol:disulphide interchange. Bovine serum albumin 
is a classic case, and there is now good evidence that 
the heterogeneity of this protein in isoelectric focussing 
arises from the existence of various disulphide-inter- 
changed isomers [43]. There is also the interesting 
possibility that intramolecular thiol:disulphide inter- 
change is of regulatory significance. Thiol proteases 
often contain disulphide bonds and it has been 
proposed that in papain, intramolecular thiol: 
disulphide interchange involving the active site thiol 
(Cys-25) and one of the enzyme's 3 disulphide bonds 
could participate in a zymogen activation system 
[44]. Brocklehurst and Kierstan [44] propose that 
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papaya latex is a storage form of papain and differs 
only in that the Cys-25 residue is involved in a 
disulphide bond, probably with either Cys-22 or 
Cys-63. 
Tyrosine aminotransferase from rat liver exists in 
3 separable forms, which may be relevant to the in vivo 
regulation of the enzyme. The forms are intercon- 
vertible in vitro, and the nature of the differences 
between them, and of factors which catalyse their 
interconversion, have been studied intensively 
[45-47]. At present the evidence suggests that the 
forms differ in free thiol content and that the cellular 
systems catalysing their interconversion are catalysts 
of thiol:disulphide interchange [45]. 
Intramolecular thiol:disulphide interchange is also 
important in the oxidation of reduced proteins 
in vitro and, presumably, in the formation of intra- 
molecularly disulphide bonded proteins in vivo. The 
best-characterised ystem is the re-oxidation of 
reduced pancreatic trypsin inhibitor by low molecular 
weight disulphides or disulphide/thiol buffers. A 
pathway for formation of the 3 native disulphide 
bonds - 5-55, 14-38, 30-51 - has been identified. 
Of the 5 possible species with one disulphide bond 
only two (Cys 5-Cys 30) and (Cys 30-Cys 51) are 
formed and these are rapidly interconverted by thiol: 
disulphide interchange [48]. A similar process occurs 
at the level of the 'two-disulphide' intermediates [49]. 
This penetrating study has many implications for the 
process of protein folding, but in this context its 
significance is that it shows clearly the importance of 
intramolecular thiol:protein disulphide interchange in 
the formation of protein disulphide bonds. 
For larger proteins with more disulphide bonds the 
pathway of disulphide formation isnot known in such 
detail. Bovine serum albumin contains 17 native 
disulphide bonds and one thiol group; theoretically 
>10 =° differently disulphide-bonded isomers can arise 
from the fully-reduced protein. The rate of reoxida- 
tion and folding of serum albumin has been studied in 
vitro using antibodies as probes of regain of elements 
of the native conformation [50-52]. The findings 
show that reoxidation is catalysed by GSH and by a 
rat liver microsomal preparation showing protein- 
disulphide isomerase activity (see below). Native 
molecules are reformed, but the process is slower 
than for smaller proteins [501. Different regions of 
the molecule regain the native conformation atslightly 
different rates. Individual domains also refold to the 
native conformation and some evidence suggests that 
the isolated omains, obtained by partial proteolysis, 
refold faster than the corresponding regions in the 
intact protein, presumably because of the lesser 
probability of forming non-native disulphide bonds 
between domains [51,52]. The conclusions are 
broadly confirmed by work on human serum albumin 
[53] which also shows that in the early stages of 
re folding much of the albumin is present as oligomers, 
which slowly convert o monomer as reoxidation 
proceeds. 
2.4. Protein-disulphide isomerization 
In addition to the intramolecular interchange just 
considered, isulphide bonds can isomerize ven in 
fully-oxidised proteins, in a process involving mixed 
disulphide formation (reaction 4). This reaction may 
be important in the formation of native disulphide 
bonds both in vitro and in vivo. 
The formation of intramolecular disulphide bonds 
from reduced proteins has been intensively studied in 
vitro, mainly to throw light on the process of protein 
folding and the formation of the native conformation. 
The nature of the oxidant in vivo is not firmly 
established [54], and in the model studies low 
molecular weight disulphides [55,56], transition 
metals in solution [57,58] and metalloproteins [59] 
have all been used as oxidants. Ribonuclease has been 
studied in most detail and the time course of oxidation 
0oss of free -SH groups) has been compared to the 
time course of conformational changes and the regain 
of native enzyme activity [56,60]. Although a certain 
amount of activity is associated with the fully-reduced 
enzyme [61 ] the time course of reoxidation is
considerably faster than that of reactivation [56,60]. 
The inactive material after short periods of oxidation 
consists of a large number of fully oxidised species 
containing non-native disulphide pairings, which then 
rearrange to the native state slowly via reaction (4) 
[56]. This is the process catalysed by protein- 
disulphide isomerase. Conformational changes 
accompanying this rearrangement have been detected. 
[56,62]. The oxidation of reduced lysozyme by 
40/~M Cu 2÷ likewise gives rise to inactive oxidised 
forms which are slowly converted to the native form 
by thiol:disulphide interchange [58]. 
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3. Enzymes eatalysing thiol:protein-disulphide int r- 
change 
In the previous ection, 3 enzymes are mentioned 
which catalyse thiol:disulphide interchange. They will 
now be considered in turn. 
3.1. Thiol:disulphide oxidoreduetase 
The first was discovered instudies on the metabolism 
of low molecular weight disulphides and mixed 
disulphides [26]. Most physiological nd non- 
physiological disulphides can be reduced in a reaction 
involving thiol: disulphide interchange with GSH 
catalysed by a thiol:disulphide oxidoreductase (t rmed 
CySSG-thioltransferase by Eriksson et al. [28]). There 
appears to be a single non-specific enzyme catalysing 
this thiol:disulphide interchange involving low 
molecular weight disulphides, and it is distinct from 
glutathione reductase and the ghitathione S-aryl- 
transferases [28]. The enzyme partially purified from 
rat liver cytosol is also active towards a protein-SSG 
mixed disulphide and towards ome protein 
disulphides [27]. A partially purified preparation 
from yeast has preference for GSH:cystine oxido- 
reduction but also catalyses reduction of bonds in 
insulin and serum albumin [63]. 
Thiol :disulphide oxidoreductases with specificity 
for protein disulphides are considerably ess well 
understood. Essentially two activities have been used 
for their analysis namely the reduction of insulin by 
GSH, to yield GSSG and reduced A and B chains 
[1-8] a type (1) reaction, and the thiol-dependent 
regain of enzyme activity from fully oxidised 
incorrectly disulphide-bonded ribonuclease ('scrambled' 
ribonuclease), a reaction of type (4) [64-75]. These 
two activities have been formally named glutathione: 
protein-disulphide (insulin) oxidoreductase 
(EC 1.8.4.2) and protein-disulphide isomerase 
(EC 5.3.4.1), respectively. The former is usually 
referred to as glutathione insulin transhydrogenase 
[1]. 
The problem of enzyme nomenclature is that we 
characteristically name an enzyme O.e., a distinct 
protein species) by the reaction it catalyses, and con- 
versely we are inclined to define an activity by a full 
enzyme title and therefore to assume we are referring 
to a distinct protein species. But when we assay an 
activity in a crude preparation we cannot ell whether 
one or several species contribute to that activity, and 
therefore we cannot ell whether the properties we 
observe are those of a definable 'enzyme'. In discussing 
the properties of glutathione insulin transhydrogenase 
and protein-disulphide isomerase it is therefore useful 
to distinguish between observations on crude systems 
and on reasonably pure preparations. 
3.2. Protein-disulphide isomerase 
Assayed by the ability to reactivate scrambled 
ribonuclease, protein-disulphide isomerase has been 
detected in all animal tissues tudied and in plant 
material [42,64-67]. In liver, the microsomal frac- 
tion has the highest specific activity [64,68,69] and 
the enzyme has been purified from this source [70]. 
Anfinsen et al. described material purified to 
homogeneity from beef liver, which has mol. wt 
42 000, contained a single free cysteine group and a 
disulphide bond [71] and catalysed regain of native 
activity from several reduced or scrambled proteins 
[68,70,72]. The purified material also catalysed the 
interchange of disulphide bonds in insulin leading to 
the formation of complex aggregates [73]. (No 
information was published on whether this material 
showed glutathione insulin transhydrogenase ctivity.) 
This work all dates from the period 1963-1967 and 
has not been repeated or extended since then. 
More recent studies of protein disulphide isomerase 
have not used material purified to homogeneity 
[36,50,69,74-77]. However partially-purified 
material (see [69]) has been shown to catalyse 
assembly of IgA and IgM from partially-reduced 
species [36] and reoxidation of reduced bovine 
serum albumin [78]. It also shows some glutathione 
insulin transhydrogenase ctivity but this is either a 
trace contaminant ora side reaction catalysed by the 
isomerase species ince although the isomerase activity 
was purified 140-fold, the transhydrogenase was only 
purified 10-fold relative to the homogenate [69]. (We 
have subsequently used ion-exchange and covalent 
chromatography to obtain preparations of protein 
disulphide isomerase with even lower relative levels of 
glutathione insulin transhydrogenase ctivity [79] .) 
3.3. Glutathione insulin transhydrogenase 
Glutathione insulin transhydrogenase hasbeen 
studied more extensively, and Varandani's group, in 
particular, has provided much information on the 
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tissue [80] and subcellular [80,81] distribution of 
this activity and its response to changes in physiological 
status [82,83]. Several groups have described purifica- 
tions of the activity from liver or pancreas [4,84-87] 
but there is little agreement on molecular properties, 
and as has been recently pointed out [87] it seems 
likely that many of these preparations are 'con- 
taminated with other proteins or partially degraded 
thiol:protein-disulphide oxidoreductases'. All prep- 
arations of glutathione insulin transhydrogenase 
which have been described show protein-disulphide 
isomerase activity but in no case has a quantitative 
assessment been made of the relative purification of 
this and the glutathione insulin transhydrogenase 
activity. 
4. One, two, many? 
The coexistence ofglutathione insulin trans- 
hydrogenase and protein disulphide isomerase activities 
in (partially) purified preparations has led to the 
persistent suggestion [85,86,88] that a single enzyme 
is responsible for both activities. However, co-purifi- 
cation studies and studies on the responses of the two 
activities to various treatments shows that this cannot 
be the case, at least for rat liver and beef liver [69,74, 
79]. It is more likely that several enzymes catalysing 
thiol: disulphide interchange with rather different 
specificities are present in liver tissue, so that an assay 
of either the transhydrogenase or the isomerase 
activity in a crude preparation i volves contributions 
from several enzyme species. This seems most 
plausible in view of the survey above which indicates 
that thiol:protein-disulphide int rchange r actions 
may be involved in numerous cellular processes; the 
reductive degradation ofpolypeptides and proteins, 
the regulation of enzyme activity and the maintenance 
ofintracellular redox buffering through the reversible 
formation of mixed disulphides, the assembly of 
secreted proteins by the formation of interchain 
disulphide bonds, the regulation of enzyme activity 
by the isomerisation of disulphide bonds, and the 
formation of native disulphide bonds within proteins 
following synthesis. All such reactions involve initial 
attack by a thiolate ( -S - )  species, and are slow at 
physiological pH, although reasonably rapid at pH 8 
and above [89]. These reactions are therefore likely 
to be enzyme-catalysed and consideration of the 
number of processes mentioned above, suggests that 
many enzymes may be involved in the catalysis of 
thiol:protein-disulphide interchange r actions. 
One could adopt alternative hypotheses atthe 
outset: 
(i) In view of the large number of different proteins 
which may undergo disulphide formation, 
isomerization and reduction and the large number 
of different disulphide bonds they can contain, 
one might assume that a correspondingly large 
number of enzymes existed; 
(ii) One could assume that this situation ecessitated 
the existence of a single non-specific enzyme; 
(iii) One could distinguish between the different ypes 
of thiol:protein-disulphide interchang e reaction, 
as in scheme I above and assume a different 
enzyme for each reaction type. 
The first assumption implies the existence of an 
implausibly large number of distinct enzymes. The 
second is possible but implies little flexibility. The 
third is again possible, but there would be problems 
of specificity; an enzyme capable of catalysing certain 
thiol:disulphide interchange r actions would surely 
catalyse others, even though it might show a distinct 
substrate preference. 
Such speculation is clearly of limited value. To 
analyse such a situation requires the application of a 
range of different assays involving different hiol and 
disulphide substrates, covering at least the range of 
reactions in scheme 1. Such an approach as proved 
useful in analogous situations. For example, awide 
range of glutathione S-transferase activities have been 
recognized in rat liver preparations; study at various 
levels of purification using a wide variety of substrates 
has shown that all the various activities reside in 5 
distinct enzyme species which have distinct, but over- 
lapping, patterns of substrate preference [90]. 
Similarly, it is now clear that the multiple mono- 
oxygenase activities in liver microsomes do not 
correspond to an immense number of distinct 
enzymes, nor to a single non-specific enzyme. A
modest number of cytochrome P-450 species can now 
be distinguished, which show different substrate 
preferences [91,92]. This field has been easier to 
resolve because of the specific induction of certain 
cytochrome P-450 species by particular inducers. 
But such an analysis has not yet been carried out 
for the thiol: protein-disulphide oxidoreductases. The 
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major assay systems used (reactivation of ribonuclease, 
and degradation of insulin) are not very flexible and 
so there have been no quantitative accounts of the 
substrate preferences of a purified enzyme prepara- 
tion as compared to its crude source. As a result, of 
course, it is difficult to be confident of the physio- 
logical roles of the various enzyme species which have 
been purified. The fact that a preparation has been 
mainly studied in terms of a particular activity does 
not guarantee that this activity represents its 
physiological function [88]. 
For example, a preparation of protein-disulphide 
isomerase from beef liver [69] was mentioned above. 
This clearly has specificity for a reaction of type (4) 
compared to several of type 1, in that relative to a 
liver homogenate it has 140-fold higher specific 
activity for reactivation of ribonuclease, but only 
10-fold higher specific activity in the glutathione 
insulin transhydrogenase reaction [69], and in other 
GSH:disulphide oxidoreductions [79]. But this 
specific preference for protein disulphide isomeriza- 
tion over other kinds of thiol:disulphide interchange 
reactions does not prove that the enzyme in this 
partially purified preparation is responsible for 
ensuring native disulphide bond formation during 
liver protein biosynthesis [93]. The use of a small, 
fully-oxidised, single-domain pancreatic protein 
substrate to assay 'protein-disulphide isomerase' is
convenient, but wider studies perhaps with reduced 
albumin, or even reduced fibrinogen are still needed 
to clarify the mechanism of disulphide formation in 
biosynthesis of liver protein. 
Similarly, the purified preparations of 'ghitathione 
insulin transhydrogenase' have not been quantitatively 
studied in terms of specificity. In no case has 
sufficient data been presented to allow one to say 
that a preparation of glutathione insulin trans- 
hydrogenase is more purified in glutathione insulin 
transhydrogenase activity than in any other thiol: 
disulphide interchange activity [86]. In fact it is 
possible that these preparations are specifically 
enriched in protein-disulphide isomerase activity since 
the published purifications of 'ghitathione insulin 
transhydrogenase' involve solubilisation with 
deoxycholate [4] or acetone xtraction [80] 
procedures which activate protein-disulphide isomerase 
but either inactivate glutathione insulin trans- 
hydrogenase or activate it only slightly [69, 94]. 
5. Conclusion 
Because of the nature of the reaction they catalyse, 
enzymes responsible for the numerous cellular 
processes involving thiol:protein-disulphide inter- 
change are likely to be active in a range of reactions 
even when purified to homogeneity. Therefore, to 
establish the physiological role of any one such 
enzyme it will be essential to characterise it fully and 
quantitatively in terms of its activity in the reactions 
types 1 -4  and with a range ofsubstrates. This requires 
the development of a number of assays (e.g., for 
reactions types 2 and 3) with a spread of substrates. 
Such a development will allow the enumeration of 
the enzymes catalysing thiol:protein-disulphide 
interchange and the elucidation of their physiological 
roles. 
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